U.K. agency rejects Eli Lilly's Mounjaro for type 2 diabetes.
The UK's National Institute for Health and Care Excellence (NICE) has declined to recommend Eli Lilly's Mounjaro, a new medication that helps patients lose weight, for people with type 2 diabetes without additional evidence. NICE has asked Lilly for more data to address the uncertainties in the clinical evidence when compared to all relevant alternative treatments.